Meta-Analysis: Spironolactone for Patients with Heart Failure with Mid-range Ejection Fraction and Heart Failure with Preserved Ejection Fraction

Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials – Medicine (free)

Related Meta-Analysis with Somewhat Conflicting Conclusions: Effects of spironolactone in heart failure with preserved ejection fraction – Medicine (free) AND Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials – BMC Medicine (free)

Related Randomized Trial: Spironolactone for Heart Failure with Preserved Ejection Fraction – New England Journal of Medicine (free)